Reference : Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablati...
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/102050
Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.
English
Baron, Frédéric mailto [Université de Liège - ULg > Département des sciences cliniques > GIGA-R : Hématologie - Département des sciences cliniques >]
Storb, Rainer [> > > >]
2005
Clinical Advances in Hematology & Oncology
3
10
799-819
No
International
1543-0790
[en] Graft vs Host Disease ; Graft vs Tumor Effect ; Hematopoietic Stem Cell Transplantation ; Humans ; Leukemia/therapy ; Lymphoma/therapy ; Transplantation Conditioning ; Transplantation, Homologous
[en] Nonmyeloablative and reduced-intensity conditioning regimens followed by allogeneic hematopoietic cell transplantation (HCT) have been evaluated in patients with hematologic malignancies who were not considered candidates for conventional HCT because of age or medical comorbidities and in selected patients with metastatic renal cell carcinoma. The regimens have relied more on graft-versus-tumor effects than on chemoradiation therapy to facilitate engraftment and eradicate malignant cells. While nonmyeloablative HCT has been associated with reduced regimen-related toxicities and has been curative for a number of patients with hematologic malignancies, challenges have remained in regard to graft-versus-host disease, infections, and disease progression. In this article, we review data from a number of published phase I and II studies that describe the results of allogeneic HCT after nonmyeloablative conditioning.
http://hdl.handle.net/2268/102050

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
H&OReview article.Baron-Storb.pdfPublisher postprint592.35 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.